La cadena de opciones muestra datos clave de las opciones de acciones de Sidus Space a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Sidus Space..

Sidus Space (NASDAQ:SIDU) Bolsa, Cadena de Opciones

Sidus Space

Sidus Space Inc is a Space and Defense as-a-Service company focused on providing complex space hardware, satellite/spacecraft design, manufacture, launch, and data solutions for both government and commercial in-space missions for all destinations through the solar system. This includes a Space-based infrastructure of multi-mission satellites with hyperspectral, multi-spectral, and other sensors to provide monitoring services and solutions to multiple sectors and industries. The company supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers.

Sidus Space Inc

SIDUS HEROES

Citigroup analyst Filippo Falorni maintains Brown-Forman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BF#NYSE">BF</a>) with a Neutral and lowers the price target from $38 to $35.

News

Price Target

Analyst Ratings

BF/B

Citigroup Maintains Neutral on Brown-Forman, Lowers Price Target to $35

Citigroup analyst Filippo Falorni maintains Monster Beverage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNST#NASDAQ">MNST</a>) with a Buy and raises the price target from $64 to $70.

MNST

Citigroup Maintains Buy on Monster Beverage, Raises Price Target to $70

Citigroup analyst Filippo Falorni maintains Estee Lauder Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) with a Neutral and lowers the price target from $77 to $55.

Citigroup Maintains Neutral on Estee Lauder Cos, Lowers Price Target to $55

Citigroup analyst Filippo Falorni maintains Newell Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWL#NASDAQ">NWL</a>) with a Neutral and lowers the price target from $7.75 to $4.75.

Citigroup Maintains Neutral on Newell Brands, Lowers Price Target to $4.75

Citigroup analyst Filippo Falorni maintains Boston Beer Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) with a Buy and raises the price target from $280 to $285.

Citigroup Maintains Buy on Boston Beer Co, Raises Price Target to $285

Citigroup analyst Piyush Avasthy maintains Zebra Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBRA#NASDAQ">ZBRA</a>) with a Neutral and lowers the price target from $371 to $250.

ZBRA

Citigroup Maintains Neutral on Zebra Technologies, Lowers Price Target to $250

Citigroup analyst Andrew Kaplowitz maintains Xylem (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYL#NYSE">XYL</a>) with a Buy and lowers the price target from $152 to $134.

Citigroup Maintains Buy on Xylem, Lowers Price Target to $134

Citigroup analyst Andrew Kaplowitz maintains Vontier (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VNT#NYSE">VNT</a>) with a Buy and lowers the price target from $45 to $36.

Citigroup Maintains Buy on Vontier, Lowers Price Target to $36

Pinnacle Finl Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PNFP#NASDAQ">PNFP</a>) reported quarterly earnings of $1.90 per share which beat the analyst consensus estimate of $1.80 by 5.56 percent. This is a 24.18 percent increase over earnings of $1.53 per share from the same period last year. The company reported quarterly sales of $462.85 million which missed the analyst consensus estimate of $478.54 million by 3.28 percent. This is a 8.11 percent increase over sales of $428.14 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

PNFP

Pinnacle Finl Partners Q1 Adj $1.90 Beats $1.80 Estimate, Sales $462.85M Miss $478.54M Estimate

Citigroup analyst Andrew Kaplowitz maintains Vertiv Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRT#NYSE">VRT</a>) with a Buy and lowers the price target from $153 to $98.

Citigroup Maintains Buy on Vertiv Holdings, Lowers Price Target to $98

Citigroup analyst Andrew Kaplowitz maintains Veralto (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VLTO#NYSE">VLTO</a>) with a Neutral and lowers the price target from $116 to $100.

VLTO

Citigroup Maintains Neutral on Veralto, Lowers Price Target to $100

ON Semiconductor Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) shares are rising in extended trading Monday after the company withdrew its <a href="https://www.benzinga.com/pressreleases/25/04/b44801990/onsemi-withdraws-proposal-to-acquire-allegro-microsystems">acquisition proposal for Allegro MicroSystems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGM#NASDAQ">ALGM</a>)</a>.
What Happened: After the market close on Monday, ON Semiconductor announced it ceased efforts to acquire Allegro MicroSystems and withdrew its all-cash proposal of $35.10 per share after determining there was &#8220;no actionable path forward.&#8221;
On Semi shares popped on the news, while Allegro MicroSystems shares traded lower by approximately 10%. 
ON Semiconductor said it will focus on other existing opportunities to enhance shareholder value. In connection with the announcement, the company said it intends to continue to allocate capital towards its existing buyback program.
&#8220;On Semi is committed to taking a disciplined approach to capital allocation and maximizing long-term stockholder value,&#8221; said Hassane El-Khoury, president and CEO of ON Semiconductor.
&#8220;While we continue to believe that a combination with onsemi would be beneficial to all stakeholders of both companies, after careful consideration, we have decided to withdraw our acquisition proposal given the reluctance of Allegro&#8217;s board of directors to fully engage and explore our proposal.&#8221;
ON Semiconductor said the company continues to see significant long-term opportunities in the automotive, industrial and AI data center markets.
ON Price Action: At publication time, <a href="http://benzinga.com/quote/on">ON Semiconductor shares</a> were up 2.47%, trading at $36.50 in Monday&#8217;s after-hours session, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/04/44801373/a-us-recession-in-2025-betting-odds-say-its-more-likely-than-not">A US Recession In 2025? Betting Odds Say It&#8217;s More Likely Than Not</a></li>
</ul>
Photo: Shutterstock.

After-Hours Center

Movers

Tech

ALGM

ON Semiconductor Stock Jumps After Withdrawing Proposal To Acquire Allegro MicroSystems

<a href="https://www.globenewswire.com/Tracker?data=rYaB3AXtBTvABdXKuHrm2p72-FAIaLz-4-JrcxwiqDX9gbEF9W0Gcgwh5cwh0g-hG-BVBSCYGdYlXoyHuOO-f0zWEM_Wm9LkcAmN83CYQtwdbBQg-cPQeGzlbXR-zgJVRpJaig66knLkDOD8qKzm_Z2fGKb0-QotehA-U7CIr7oXl94vQLTOcvbYkjdV4kejzMNsX90vgwl0PbjZfJs3dws3tkIl4Ew9_P4e3lTcRhaL4ej2GmYyoNNy38knBpHnDM_lBCJScxQQq4jjTorBwEEYr9e7ZQlKuLCbQ3qgNe4gQRzjGHQiO46alSfSEiyXQnkzwJGk-QS7RAolIheMnt7xbpjn-7-tYilbVOwxVic4EqKvFDQwc4XJdNDIRbVscxHd-pggMTVTRROyqLWB1dGh1lnzqWZ08xNYronYBNoJ-p8k3h52-jb9vYVuEAj0M-bAQu_cYdp9rY5y2LW5C7PvRoa65Mui5OziwOcBPDJLQjGcrs2pCFYIWTZNDDRY">Cue Biopharma, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CUE#NASDAQ">CUE</a>), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of cancer and autoimmune disease, today announced that it is commencing an underwritten public offering of shares of its common stock (or pre-funded warrants to purchase common stock in lieu thereof) and accompanying warrants to purchase shares of common stock. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed or as to the actual size or terms of the offering. All of the securities are being offered by Cue Biopharma.
Oppenheimer &amp; Co. Inc. is acting as sole book-running manager for the offering. Newbridge Securities Corporation is acting as co-manager for the offering.

Offerings

Cue Biopharma Announces Proposed Public Offering; No Size Or Amount Disclosed

<h3>Gainers</h3>
<ul>
<li>Solo Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DTC#NYSE">DTC</a>) stock moved upwards by 6.7% to $0.15 during Monday's after-market session. The company's market cap stands at $9.1 million. </li>
<li>Jiade (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JDZG#NASDAQ">JDZG</a>) shares moved upwards by 5.27% to $0.57. The company's market cap stands at $13.8 million. </li>
<li>Target Hospitality (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TH#NASDAQ">TH</a>) stock rose 4.98% to $6.95. The market value of their outstanding shares is at $690.5 million. </li>
<li>Leslies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LESL#NASDAQ">LESL</a>) shares moved upwards by 4.91% to $0.57. The market value of their outstanding shares is at $106.3 million. </li>
<li>Twin Hospitality Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWNP#NASDAQ">TWNP</a>) stock increased by 4.88% to $6.65. The market value of their outstanding shares is at $333.6 million. </li>
<li>Grove Collaborative Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GROV#NYSE">GROV</a>) shares moved upwards by 4.58% to $1.14. The market value of their outstanding shares is at $45.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Gogoro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GGR#NASDAQ">GGR</a>) shares declined by 8.8% to $0.29 during Monday's after-market session. The market value of their outstanding shares is at $84.6 million. </li>
<li>Wah Fu Education Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WAFU#NASDAQ">WAFU</a>) stock decreased by 7.7% to $1.32. The market value of their outstanding shares is at $5.8 million. </li>
<li>Phoenix Motor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEV#NASDAQ">PEV</a>) stock declined by 7.58% to $0.24. The market value of their outstanding shares is at $11.0 million. </li>
<li>NWTN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWTN#NASDAQ">NWTN</a>) shares decreased by 6.64% to $0.35. The market value of their outstanding shares is at $101.5 million. </li>
<li>MakeMyTrip (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMYT#NASDAQ">MMYT</a>) stock decreased by 4.9% to $93.06. The company's market cap stands at $10.2 billion. </li>
<li>Genius Gr (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GNS#AMEX">GNS</a>) shares fell 4.79% to $0.24. The company's market cap stands at $18.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GROV

JDZG

LESL

MMYT

NWTN

TWNP

WAFU

12 Consumer Discretionary Stocks Moving In Monday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Precision Optics Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POCI#NASDAQ">POCI</a>) stock rose 21.4% to $4.7 during Monday's after-market session. The company's market cap stands at $35.8 million. </li>
<li>Healthcare Triangle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) stock increased by 15.01% to $0.25. The market value of their outstanding shares is at $11.0 million. </li>
<li>BioSig Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSGM#NASDAQ">BSGM</a>) shares rose 9.52% to $0.69. The company's market cap stands at $16.4 million. </li>
<li>Venus Concept (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERO#NASDAQ">VERO</a>) shares moved upwards by 8.26% to $4.06. The market value of their outstanding shares is at $2.6 million. </li>
<li>BioAtla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCAB#NASDAQ">BCAB</a>) shares moved upwards by 7.83% to $0.34. The company's market cap stands at $19.8 million. </li>
<li>NanoVibronix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAOV#NASDAQ">NAOV</a>) stock increased by 7.61% to $8.34. The market value of their outstanding shares is at $6.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Geovax Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOVX#NASDAQ">GOVX</a>) shares decreased by 29.9% to $0.75 during Monday's after-market session. The market value of their outstanding shares is at $7.0 million. </li>
<li>Krystal Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRYS#NASDAQ">KRYS</a>) stock fell 16.07% to $141.77. The company's market cap stands at $4.0 billion. </li>
<li>Seres Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCRB#NASDAQ">MCRB</a>) stock declined by 13.67% to $0.56. The company's market cap stands at $98.4 million. </li>
<li>Minerva Neurosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NERV#NASDAQ">NERV</a>) stock declined by 12.11% to $1.38. The market value of their outstanding shares is at $9.6 million. </li>
<li>cbdMD (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) stock decreased by 10.42% to $0.21. The company's market cap stands at $1.3 million. </li>
<li>Curis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRIS#NASDAQ">CRIS</a>) stock decreased by 9.31% to $1.17. The market value of their outstanding shares is at $12.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BCAB

BSGM

CRIS

GOVX

HCTI

KRYS

MCRB

NAOV

NERV

POCI

VERO

YCBD

12 Health Care Stocks Moving In Monday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Techprecision (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPCS#NASDAQ">TPCS</a>) stock moved upwards by 7.5% to $2.58 during Monday's after-market session. The company's market cap stands at $24.9 million. As per the press release, Q3 earnings came out 4 days ago. </li>
<li>United Maritime (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USEA#NASDAQ">USEA</a>) shares rose 6.14% to $1.21. The company's market cap stands at $10.7 million. </li>
<li>SUNation Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SUNE#NASDAQ">SUNE</a>) stock moved upwards by 5.92% to $0.03. </li>
<li>Rocket Lab USA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) stock rose 5.85% to $20.25. The market value of their outstanding shares is at $9.1 billion. </li>
<li>GEE Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/JOB#AMEX">JOB</a>) stock moved upwards by 5.74% to $0.19. The market value of their outstanding shares is at $21.1 million. </li>
<li>ClearSign Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLIR#NASDAQ">CLIR</a>) shares rose 4.99% to $0.59. The market value of their outstanding shares is at $29.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>YY Group Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YYGH#NASDAQ">YYGH</a>) shares fell 10.9% to $1.1 during Monday's after-market session. The market value of their outstanding shares is at $42.0 million. </li>
<li>iPower (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPW#NASDAQ">IPW</a>) shares fell 5.68% to $0.5. The company's market cap stands at $15.7 million. </li>
<li>Roma Green Finance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROMA#NASDAQ">ROMA</a>) stock decreased by 5.67% to $1.0. The market value of their outstanding shares is at $15.5 million. </li>
<li>WANG &amp; LEE Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WLGS#NASDAQ">WLGS</a>) shares fell 5.53% to $0.21. The company's market cap stands at $4.4 million. </li>
<li>Hong Kong Pharma Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HKPD#NASDAQ">HKPD</a>) stock declined by 5.52% to $1.2. The company's market cap stands at $13.2 million. </li>
<li>Jayud Global Logistics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JYD#NASDAQ">JYD</a>) stock fell 5.33% to $0.37. The market value of their outstanding shares is at $35.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CLIR

HKPD

RKLB

ROMA

SUNE

TPCS

USEA

WLGS

YYGH

12 Industrials Stocks Moving In Monday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>ARB IOT Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARBB#NASDAQ">ARBB</a>) shares moved upwards by 62.5% to $1.04 during Monday's after-market session. The company's market cap stands at $27.4 million. </li>
<li>Xperi (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPER#NYSE">XPER</a>) shares rose 8.98% to $7.16. The company's market cap stands at $325.9 million. </li>
<li>Saiheat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIH#NASDAQ">SAIH</a>) shares rose 8.04% to $4.43. The market value of their outstanding shares is at $7.5 million. </li>
<li>Ascent Solar Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTI#NASDAQ">ASTI</a>) shares increased by 7.46% to $1.44. The market value of their outstanding shares is at $2.4 million. </li>
<li>Foxx Development Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOXX#NASDAQ">FOXX</a>) shares increased by 6.27% to $4.91. The market value of their outstanding shares is at $35.7 million. </li>
<li>Bit Origin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTOG#NASDAQ">BTOG</a>) shares moved upwards by 5.73% to $0.15. The company's market cap stands at $1.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Allegro Microsystems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGM#NASDAQ">ALGM</a>) shares decreased by 12.3% to $19.3 during Monday's after-market session. The company's market cap stands at $3.5 billion. </li>
<li>Signing Day Sports (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SGN#AMEX">SGN</a>) shares declined by 11.87% to $0.66. The market value of their outstanding shares is at $1.2 million. </li>
<li>Applied Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLD#NASDAQ">APLD</a>) shares declined by 10.99% to $4.78. The company's market cap stands at $1.0 billion. As per the press release, Q3 earnings came out today. </li>
<li>Auddia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) shares decreased by 9.08% to $4.01. The market value of their outstanding shares is at $2.0 million. </li>
<li>AEye (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIDR#NASDAQ">LIDR</a>) stock declined by 8.22% to $0.58. The company's market cap stands at $10.5 million. </li>
<li>UTime (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTO#NASDAQ">WTO</a>) stock declined by 6.15% to $1.68. The market value of their outstanding shares is at $43.4 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

APLD

ARBB

ASTI

AUUD

BTOG

FOXX

LIDR

SAIH

XPER

12 Information Technology Stocks Moving In Monday's After-Market Session

As previously disclosed on the Form 8-K dated April 9, 2025,&nbsp;Primis Financial Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRST#NASDAQ">FRST</a>) (the "Company"), submitted a hearing request ("Hearing Request") to The Nasdaq Stock Market LLC ("Nasdaq") appealing Nasdaq's delisting determination and requesting a stay of delisting of the Company's securities pending a final written decision by the Nasdaq Hearings Panel (the "Panel").
On April 10, the Company received a response letter from the Nasdaq Hearings Advisor setting the hearing for Thursday, May 15, 2025 and staying the delisting determination pending a final written decision by the Panel.
The Company plans to file the Form 10-K for the year ending December 31, 2024 as promptly as practicable and currently expects to do so prior to the hearing, at which point the Company will be in compliance with the Nasdaq Listing Rules.

FRST

Primis Financial Receives Receipt Of Stay From Nasdaq;  Company Received A Response Letter From The Nasdaq Hearings Advisor Setting The Hearing For Thursday, May 15, 2025

Citigroup analyst Andrew Kaplowitz maintains Symbotic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYM#NASDAQ">SYM</a>) with a Buy and lowers the price target from $37 to $29.

Citigroup Maintains Buy on Symbotic, Lowers Price Target to $29

<ul>
<li>Partnership bolsters Boehringer's autoimmune and inflammatory disease pipeline portfolio aiming to tackle areas of high unmet patient need. &nbsp;</li>
<li>The agreement focuses on further research and development of a novel, first-in-class bispecific compound for T cell mediated targeted depletion of specific B cells to address autoimmune and inflammatory diseases. &nbsp;</li>
<li>The candidate compound has the potential to reach patients with autoimmune diseases earlier in their treatment journey and achieve long-term disease control by reducing targeted B cell populations. &nbsp;</li>
</ul>
INGELHEIM, Germany and BOSTON, April 14, 2025 (GLOBE NEWSWIRE) -- Boehringer Ingelheim and Cue Biopharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CUE#NASDAQ">CUE</a>) today announced a strategic research collaboration and license agreement to develop and commercialize Cue Biopharma's CUE-501 product candidate, a differentiated B cell depletion therapy for autoimmune diseases. Cue Biopharma is a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the potential treatment of autoimmune and inflammatory diseases.
Cue Biopharma's preclinical candidate molecule binds to a B cell specific membrane protein and in parallel selectively engages virus-specific memory killer T cells. This enables it to selectively deplete B cells and dampen autoimmune and inflammatory processes, potentially offering improved benefit and safety versus other therapeutic approaches targeting B cells.

Biotech

General

Cue Biopharma And Boehringer Ingelheim Announce Strategic Partnership To Develop And Commercialize First-in-Class Bispecific T Cell-Engaging B Cell Depletion Therapy CUE-501 For Autoimmune And Inflammatory Diseases, Aiming For Earlier Intervention And Long-Term Disease Control

Press Releases

Sidus Space Mourns the Death of Board Member Richard Berman

Sidus Space Celebrates One Year in Orbit for LizzieSat™-1 While Advancing the Future of Space Innovation

Sidus Space and Warpspace Sign MOU to Launch Joint Venture to Develop Advanced Optical Space Communication

Sidus Space LizzieSat™-3 to Launch March 14, 2025, with Next Generation AI-Driven Space-to-Space Data Relay

Sidus Space Successfully Launches LizzieSat™-3, Expanding AI-Driven On-Orbit Capabilities

Sidus Space to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on March 31 at 5:00 p.m. ET

Sidus Space Expands Global Reach in Asia With Its Proprietary Sidus Orlaith™ AI Ecosystem

Sidus Space Reports Full-Year 2024 Financial Results and Provides Business Updates

Sidus Space Signs Extended and Amended Preliminary $120M Agreement with Lonestar for Lunar Data Storage Spacecraft

Sidus Space and Reflex Aerospace Sign MOU to Launch Joint Venture for Global Satellite Solutions

Comments

Sidus Space

Sidus Space (SIDU) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL